International Journal of Drug Delivery Technology
Volume 14, Issue 3

Drug Delivery System That Self-Emulsify: Transportation of Drug From Gut to Target Organs

Jaiswal Nilesh*, Mehta Parulben

School of Pharmacy, L.N.C.T University, Bhopal, Madhya Pradesh, India. 

Received: 15 th March, 2024; Revised: 23rd May, 2024; Accepted: 13th August, 2024; Available Online: 25th September, 2024 

ABSTRACT

Microemulsions are highly popular for their specific uses, including vivid applications and this is due to their special properties, which include very high interfacial interactions with demonstrated stability from a thermodynamics point of view, and on the other hand, also very low interfacial tension, which is required to solubilize highly immiscible dispersions. This review’s goal is to briefly outline potential uses of micro-emulsion systems, their uses, limitations and possible in-vitro and in-vivo techniques. To characterise such dispersion systems, it is commonly known that adding the right surfactant or surfactant mixture can combine large amounts of two non-dissolving-target liquids, such as water and oil, into a single phase that is macroscopically homogeneous but microscopically heterogeneous. Owing to the advantages of lymph drug delivery, the drug-lipid conjugates, when they enter the lymph route, become an ideal approach for enhancing the absorption of such drugs to combat metastatic cancers of the lymph nodes and their drainage to specific organ systems where the cancer is already spread. As the route of lymph delivery is important where a tumor has already been cancerous, this formulation approach has distinct opportunities to transport needy molecules to cancerous sites in various organs, which also includes the lymph nodes. This review, particularly, lays more stress on an overview of microemulsions in general, the in-vivo and in-vitro characterization methods and potential applications related to target drug delivery via the lymphatic circulatory system.

Keywords: Self-emulsify microemulsions, Lymphatic drug delivery, In-vitro and in-vivo characterization, Thermodynamic stability, Emulsions in-situ behavior.

International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.3.73

How to cite this article: Nilesh J, Parulben M. Drug Delivery System That Self-Emulsify: Transportation of Drug From Gut to Target Organs. International Journal of Drug Delivery Technology. 2024;14(3):1765-1772.

REFERENCES

  1. Chen CH, Chang CC, Shih TH, Aljuffali IA, Yeh TS, Fang JY. Self-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass International Journal of Nanomedicine. 2015:2403-2416.Available from: doi.org/10.2147/IJN.S79522
  2. Nakmode D, Bhavana V, Thakor P, Madan J, Singh PK, Singh SB, Rosenholm JM, Bansal KK, Mehra NK. Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Pharmaceutics. 2022;14(4):831. Available from: doi.org/10.3390/ pharmaceutics14040831.
  3. Jaiswal P, Aggarwal G, Harikumar SL, Singh K. Development of self-microemulsifying drug delivery system and solid self-microemulsifying drug delivery system of telmisartan. International Journal of Pharmaceutical 2014;4(4):195-206. Available from: doi.org/10.4103/2230- 973X.143123.
  4. Tartaro G, Mateos H, Schirone D, Angelico R, PalazzoMicroemulsion Microstructure(s): A Tutorial Review. Nanomaterials. 2020; 10(9):1657. Available from: doi.org/10.3390/ nano10091657.
  5. Nielloud F, Marti‐Mestres G, Salager 1st Edition. PharmaceuticalEmulsions and Suspensions; 2000.
  6. Ceschel G, Bergamante V, Maffei P, Borgia SL, Calabrese V, Biserni S, Ronchi C. Solubility and Transdermal Permeation Properties of aDehydroepiandrosterone Cyclodextrin Complex from Hydrophilic and Lipophilic Drug Delivery. 2008; 12(5):275–280. Available from: doi.org/10.1080/10717540500176563
  7. Texter J, Ziemer Polyurethanes via Microemulsion Polymerization. Macromolecules. 2004; 37(16):5841–5843. Available from: doi.org/10.1021/la970990a
  8. Szumała P, Kaplińska J, Makurat-Kasprolewicz B, ManiaMicroemulsion Delivery Systems with Low Surfactant Concentrations: Optimization of Structure and Properties by Glycol Cosurfactants. Molecular Pharmaceutics. 2023;20(1):232-Available from: doi.org/10.1021/acs.molpharmaceut.2c00599
  9. Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. Journal of Pharmaceutical Sciences. 1993; 82(10):979-987.
  10. Mundada V, Patel M, Sawant Submicron Emulsions and Their Applications in Oral Delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2016; 33(3):265-308. Available from: doi. org/10.1615/CritRevTherDrugCarrierSyst.2016017218.
  11. Rezhdo O, Speciner L, Carrier Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement. Journal of Controlled Release. 2016; 240 (10):544-560. Available from: doi.org/10.1016/j.jconrel.2016.07.050.
  12. Yáñez JA, Wang SW, Knemeyer IW, Wirth MA, Alton KB. Intestinal lymphatic transport for drug Advanced Drug Delivery Reviews. 2011;63(10):923-942. Available from: doi. org/10.1016/j. addr.2011.05.019.
  13. Preeti, Sambhakar S, Saharan R, Narwal S, Malik R, Gahlot V,Khalid A, Najmi A, Zoghebi K, Halawi MA, Albratty M, MohanExploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A Review. Saudi Pharmaceutical Journal. 2023; 31(12):1-20. Available from: doi.org/ 10.1016/j. jsps.2023.101870.
  14. Yousef M, Park C, Henostroza M, Bou Chacra N, Davies NM, Löbenberg R. Development of a Novel In-vitro Model to Study Lymphatic Uptake of Drugs via Artificial Chylomicrons. Pharmaceutics. 2023; 15(11):2532. Available from: doi.org/ 10.3390/ pharmaceutics15112532.
  15. Fu Y, Xiao S, Liu S, Chang Y, Ma R, Zhang Z, HeAtomistic Insights into the droplet size evolution during selfmicroemulsification.  Langmuir.  2022  ;38(10):3129-3138.Available from: doi.org/10.1021/acs.langmuir.1c03099.
  16. Lombardo D, Calandra P, Kiselev MA. Structural Characterization of Biomaterials by Means of Small Angle X-rays and Neutron Scattering (SAXS and SANS), and Light Scattering Molecules. 2020; 25(23):5624. Available from: doi.org/10.3390/ molecules25235624.
  17. Yu M, Ma H, Lei M, Li N, Tan In-vitro/in-vivo characterization of nano-emulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties. European Journal of Pharmaceutics and Biopharmaceutics. 2014 ;88 (1) :92-103. Available from: doi.org/10.1016/j.ejpb.
  18. Hung WH, Chen PK, Fang CW, Lin YC, Wu Preparation and Evaluation of Azelaic Acid Topical Microemulsion Formulation: In-vitro and In-vivo Study. Pharmaceutics. 2021;13(3):410. Available from: doi.org/10.3390/pharmaceutics13030410.
  19. Dalla E, Koumentakou I, Bikiaris N, Balla E, Lykidou S, Nikolaidis N. Formulation Characterization and Evaluation of Innovative O/W Emulsions Containing Curcumin Derivatives with Enhanced Antioxidant Antioxidants. 2022;11(11):2271. Available from: doi.org/10.3390/antiox11112271.
  20. Bakhle SS, Avari Development and Characterization of Solid Self-emulsifying Drug Delivery System of Cilnidipine. Chemical and Pharmaceutical Bulletin. 2015; 63(6):408-417. Available from: doi.org/10.1248/ cpb.c14-00326.
  21. Zhang Z, Lu Y, Qi J, Wu W. An update on oral drug delivery via intestinal lymphatic transport. Acta Pharmaceutica Sinica2021;11(8):2449-2468. Available from: doi.org/10.1016/j.apsb.2020.12.022.
  22. Williams HD, Ford L, Igonin A, Shan Z, Botti P, Morgen MM, Hu G, Pouton CW, Scammells PJ, Porter CJH, Benameur H. Unlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid forms. Advanced Drug Delivery 2019;142 (3) :75-90. Available from: doi.org/10.1016/j. addr.2019.05.008.
  23. Akula S, Gurram AK, Devireddy SR. Self-Microemulsifying Drug Delivery Systems: An Attractive Strategy for Enhanced Therapeutic Profile. International Scholarly Research Notices. 2014; 14:1-11. Available from: org/10.1155/2014/964051.
  24. Ling SS, Magosso E, Khan NA, Yuen KH, Barker Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Development and Industrial Pharmacy. 2006;32(3):335-345. Available from: doi. org/ 10.1080/03639040500519102.
  25. Ye JY, Chen ZY, Huang CL, Huang B, Zheng YR, Zhang YF, Lu BY, He L, Liu CS, Long XY. A Non-Lipolysis Nano emulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied. International Journal of Nanomedicine. 2020; 8(15): 6503-6518. Available from: org/10.2147/IJN.S259993.
  26. Ryšánek P, Grus T, Šíma M, Slanař O. Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties. Pharmaceutical Research. 2020;37(9):1-7. Available from: doi.org/10.1007/s11095-020- 02858-0.
  27. Harisa GI, Sherif AY, Alanazi FK. Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons. The Journal of Membrane 2023; 256(3):199-Available from: doi.org/10.1007/s00232-023-00280-2
  28. Parayath NN, Nehoff H, Müller P, Taurin S, Greish K. Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery - dual uptake through enterocytes and M-cells. International Journal of Nanomedicine. 2015; 10: 4653-4667. Available from: doi.org/10.2147/IJN.S87681.
  29. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. The Journal of Immunology. 2004;173(2):797-806. Available from: doi.org/10.4049/ jimmunol.173.2.797.
  30. Pooja D, Kulhari H, Kuncha M, Rachamalla SS, Adams DJ, Bansal V, Sistla R. Improving Efficacy, Oral Bioavailability, and Delivery of Paclitaxel Using Protein-Grafted Solid Lipid Molecular Pharmaceutics. 2016;13(11):3903-3912. Available from: doi.org/10.1021/acs.molpharmaceut.6b00691.
  31. Colino CI, Lanao JM, Gutierrez-Millan Targeting of Hepatic Macrophages by Therapeutic Nanoparticles. Frontiers in Immunology. 2020;11(3):218. Available from: doi.org/10.3389/ fimmu.2020.00218.
  32. Chekkilla B, Raghuveer Development of Nasal In-situ Gel containing Piribedil SLN. International Journal of Pharmaceutical Quality Assurance. 2024;15(1):199-209. Available from: doi.org/10.25258/ijpqa.15.1.31.
  33. Patil MR, Kshirsagar SK. Formulation, Optimization and Evaluation of Solid SMEDDS of Itraconazole in Effervescent Granules International Journal of Pharmaceutical Quality Assurance. 2024;15(1):273-287. Available from: doi.org/10.25258/ ijpqa.15.1.42.
  34. Suttee A, Singh G, Yadav N, Pratap Barnwal R, Singla N, Prabhu KS, Mishra V. A review on status of nanotechnology in pharmaceutical International Journal of Drug Delivery Technology. 2019; 9(1): 98-103. Available from: doi.org/ 10.25258/ ijddt.9.1.16.
  35. Dinanti FP, Erawati T, Hariyadi Development of Inhaled Tuberculosis Microparticle using Polysaccharide Polymers Containing Rifamycin Groups: In-vitro and In-vivo Study. International Journal of Drug Delivery Technology. 2024;14(2):1116-1123. Available from: doi.org/10.25258/ ijddt.14.2.77